Gamida Cell
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
673 Boylston St Apt 4, Boston, Massachus...Phone Number
(617) 892-9080Website
www.gamida-cell.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
2
1
1
1
1
About Gamida Cell
Founded in 1998, Gamida Cell is a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company is headquartered in Boston, MA.Explore more
Gamida Cell Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Gamida Cell your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Gamida Cell
Click to see if Gamida Cell had a recent Job posting/layoffs
Check out if Gamida Cell is spiking on competitors!
Gamida Cell, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Check if Gamida Cell has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Gamida Cell recently announced quarterly report
Funding: Get notified immidiatlly once Gamida Cell has new funding data
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Gamida Cell launches new products
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Gamida Cell
Compare insights from companies similar to Gamida Cell, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Gamida Cell is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Gamida Cell is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Gamida Cell.
Gamida Cell financials insights
Gather financial insights about Gamida Cell, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2021
Debt
$75M
2022
Debt
$25M
Gamida Cell Tech Stack
A closer look at the technologies used by Gamida Cell
Most Recent Scoops
Person-Based
Open Position
Open Position
Open Position
Open Position
Gamida Cell News & Media
BioLineRx, Ayrmid enter license agreement for motixafortide through Gamida Cell
BioLineRx (BLRX) and Ayrmid, the parent company of Gamida Cell (GMDA), announced that the companies entered into a license agreement for motixafortide, BioLineRx’s FDA-approved stem cell mobilization agent indicated in combination with filgrastim for collection and subsequent autologous transplantation in patients with multiple myeloma. Under the terms of the agreement, BioLineRx granted Ayrmid an exclusive license to develop and commercialize Aphexda across all indications, excluding solid tumoBioLineRx and Ayrmid Ltd. Enter into Exclusive License Agreement to Commercialize APHEXDA® (motixafortide) through Gamida Cell Ltd.
– BioLineRx to receive $10 million upfront payment from Ayrmid Ltd. (parent company of Gamida Cell) plus up to $87 million in commercial milestones, as well as royalties on net sales ranging from 18% to 23% – – BioLineRx retains rights to develop and commercialize motixafortide in solid...Gamida Cell Announces New Leadership Under Ownership of Highbridge Capital Management
BOSTON--(BUSINESS WIRE)--Gamida Cell (the “Company”), a cell therapy pioneer working to turn cells into powerful therapeutics, today announced new executive leadership following a successful restructuring transaction ("Transaction”) with certain funds managed by Highbridge Capital Management, LLC (collectively, “Highbridge”) on May 24, 2024. As part of the Transaction, Highbridge invested $30 million of new capital into Gamida Cell, and is expected to provide substantial additional capital to sGamida Cell Ltd. (GMDA) Q4 2023 Earnings Call Transcript
Gamida Cell Ltd. (NASDAQ:NASDAQ:GMDA) Q4 2023 Earnings Conference Call March 27, 2024 8:30 AM ETCompany ParticipantsMike Kuczkowski - Corporate...
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Gamida Cell
Sign Up For FreeTo access detailed company insights
Founded in 1998, Gamida Cell is a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious blood diseases. The company is headquartered in Boston, MA.... Read More
